SEC 13F Intelligence

Glenmede Trust Co Na / JNJ

Glenmede Trust Co Na’s Johnson & Johnson Position

Does Glenmede Trust Co Na own Johnson & Johnson (JNJ)? Yes — 1.38M shares worth $338M (+1.66% of its 13F portfolio) as of Q1 2026, down from 1.40M shares the prior filed quarter.

Position Value
$338M
Q1 2026
Shares
1.38M
% of Portfolio
+1.66%
Quarters Held
28
currently held

Position History JNJ

Reported value by quarter
Q4 ’18: $261MQ4 ’18Q1 ’19: $280MQ2 ’19: $281MQ3 ’19: $246MQ4 ’19: $271MQ4 ’19Q1 ’20: $271MQ2 ’20: $254MQ3 ’20: $291MQ4 ’20: $327MQ4 ’20Q1 ’21: $371MQ2 ’21: $347MQ3 ’21: $310MQ4 ’21: $326MQ4 ’21Q1 ’22: $312MQ2 ’22: $307MQ3 ’22: $283MQ4 ’22: $303MQ4 ’22Q1 ’23: $263MQ2 ’23: $263MQ3 ’23: $259MQ4 ’23: $259MQ4 ’23Q1 ’24: $250MQ2 ’24: $236MQ3 ’24: $269MQ4 ’24: $208MQ4 ’24Q1 ’25: $235MQ4 ’25: $290MQ1 ’26: $338Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.38M$338M+1.66%
Q4 20251.40M$290M+1.38%
Q1 20251.42M$235M+1.26%
Q4 20241.44M$208M+1.06%
Q3 20241.66M$269M+1.29%
Q2 20241.61M$236M+1.20%
Q1 20241.58M$250M+1.25%
Q4 20231.65M$259M+1.34%
Q3 20231.66M$259M+1.48%
Q2 20231.70M$263M+1.49%
Q1 20231.70M$263M+1.49%
Q4 20221.72M$303M+1.78%
Q3 20221.74M$283M+1.79%
Q2 20221.73M$307M+1.80%
Q1 20221.76M$312M+1.53%
Q4 20211.91M$326M+1.55%
Q3 20211.92M$310M+1.61%
Q2 20212.11M$347M+1.79%
Q1 20212.26M$371M+2.00%
Q4 20202.08M$327M+1.80%
Q3 20201.95M$291M+1.74%
Q2 20201.80M$254M+1.55%
Q1 20201.86M$271M+1.23%
Q4 20191.86M$271M+1.23%
Q3 20191.90M$246M+1.13%
Q2 20192.02M$281M+1.23%
Q1 20192.00M$280M+1.27%
Q4 20182.02M$261M+1.27%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Glenmede Trust Co Na’s full portfolio or all institutional holders of JNJ.